An uptick in clinical trials and demand for advanced therapy medicinal products (ATMPs) have offered compelling opportunities for contract research organizations (CROs). The U.S. National Library of Medicine notes that around 83,230 clinical trial studies are currently active and/or recruiting globally. Amidst stiff competition and the soaring USD 1.5 trillion industry of medical device and drugs, acquisitions of small-scale innovative players, outsourcing and R&D activities have become noticeable. Outsourcing of clinical trials to CROs is mainly attributed to technical prowess and cost-effectiveness. 

With the huge repository of Grand View Research, the study will offer a bird’s eye view of financial performance, including but not limited to EBIT/EBITA, total revenue, net income, net profit, working capital, income & cash flow and Debt/Equity ratio. The report will offer a deep dive of major service/s rendered by top 50 CROs. The final report, along with the database, will peruse into following dynamics:

• Organization structure and team composition of the listed CROs.
• Stock exchange performance, including earnings per share, P/E ratio and quick ratio.
• Global penetration with the regional level breakdown.
• SWOT analysis, patient recruitment platforms/partners, special recognition/awards by industry, service benchmarking and growth plans.

Get your copy or request for a free sample of the report “Competitive Landscape of Top 50 Contract Research Organizations (CROs),” compiled and published by Grand View Research.

Top 50 CROs' Competitive Landscape Report Coverage